Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)

Clinical trial NCT03385239 · COMPLETED

Trial details

NCT number: NCT03385239
Sponsor: Akcea Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertriglyceridemia Cardiovascular Diseases

Start date: 2018-01-30
Primary completion: 2019-11-25
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.